92 related articles for article (PubMed ID: 20854406)
1. Systemic therapies containing ethanol and gelatine excipients.
Laws PM; Warren RB
Br J Dermatol; 2010 Oct; 163(4):885-6. PubMed ID: 20854406
[No Abstract] [Full Text] [Related]
2. [Composition of topical drugs].
Zerrouk N; Arnaud P
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S27-9. PubMed ID: 17563711
[No Abstract] [Full Text] [Related]
3. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
Noiles K; Vender R
J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
[TBL] [Abstract][Full Text] [Related]
4. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
Mravčík V; Skařupová K; Orlíková B; Zábranský T; Karachaliou K; Schulte B
Int J Drug Policy; 2011 Mar; 22(2):172-3. PubMed ID: 21242079
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacopeia and preparations for cutaneous application].
Esnault F; Etchegaray JP; Mallard C
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
[No Abstract] [Full Text] [Related]
6. [New formulations in dermatology].
Fredon L; Mallard C
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S30-6. PubMed ID: 17563712
[No Abstract] [Full Text] [Related]
7. Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study.
Esposito E; Menegatti E; Cortesi R
J Cosmet Sci; 2004; 55(3):253-64. PubMed ID: 15264053
[TBL] [Abstract][Full Text] [Related]
8. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
Crum M; Elkordy AA; Zarara M; Elkordy EA
Pharm Dev Technol; 2013; 18(6):1379-90. PubMed ID: 22992055
[TBL] [Abstract][Full Text] [Related]
9. Gelatine enhances drug dispersion in alginate bilayer film via the formation of crystalline microaggregates.
Thu HE; Ng SF
Int J Pharm; 2013 Sep; 454(1):99-106. PubMed ID: 23856162
[TBL] [Abstract][Full Text] [Related]
10. [Preformulatory research on model soft gel capsule containing liquid filling with constant ibuprofen content].
Dobrzyński ŁJ; Zgoda MM
Polim Med; 2011; 41(1):67-71. PubMed ID: 21744659
[TBL] [Abstract][Full Text] [Related]
11. [The influence of macromolecular excipients on the process of mass transfer at the boundary phase from a model anti-dandruff preparation into the external compartment under in vitro conditions].
Kołodziejczyk MK; Zgoda MM
Polim Med; 2012; 42(1):79-88. PubMed ID: 22783736
[TBL] [Abstract][Full Text] [Related]
12. [Excipients and new topical forms in dermatology].
Delattre L
J Pharm Belg; 1993; 48(4):261-9. PubMed ID: 8410631
[No Abstract] [Full Text] [Related]
13. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
Queille-Roussel C; Hoffmann V; Enevold A; Ganslandt C
J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid excipients - matrix agents for sustained drug delivery.
Rosiaux Y; Jannin V; Hughes S; Marchaud D
J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
[TBL] [Abstract][Full Text] [Related]
15. Permeation and skin retention of quercetin from microemulsions containing Transcutol® P.
Censi R; Martena V; Hoti E; Malaj L; Di Martino P
Drug Dev Ind Pharm; 2012 Sep; 38(9):1128-33. PubMed ID: 22188183
[TBL] [Abstract][Full Text] [Related]
16. Advances in psoriasis therapy.
Koo J; Nguyen Q; Gambla C
Adv Dermatol; 1997; 12():47-72; discussion 73. PubMed ID: 8973735
[No Abstract] [Full Text] [Related]
17. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
18. [Optimization of molding technics of xiaochuang granules by central composite design-response surface methodology].
Chen WW; Nong YM; Liang D; Deng CC; Luo B
Zhong Yao Cai; 2010 May; 33(5):801-4. PubMed ID: 20873568
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties, in vitro release and skin permeation studies of a topical formulation of standardized pomegranate rind extract.
Mo J; Kaewnopparat N; Songkro S; Panichayupakaranant P; Reanmongkol W
Pak J Pharm Sci; 2015 Jan; 28(1):29-36. PubMed ID: 25553706
[TBL] [Abstract][Full Text] [Related]
20. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
